INDEC Biosystem Inc.
Targeson Inc.
ChinaBio LLC
U.S. National Cancer Institute
China SFDA
Preclinical Study
Pharmacokinetics and Non-GLP Toxicity

The preclinical testing stage of drug development involves obtaining critical pharmacokinetic and safety data, which are important to help clients quickly and cost-effectively identify which compounds are unlikely to succeed in clinical trails.  Origin can currently provide the following services. We have also formed alliances with companies capable of providing full bioanalytical services, complete pharmacokinetic and metabolism analysis and GLP toxicity study in large animals.

•All routes of administration study (IP, IV, PO, SC etc.)
•Dose range finding study
•In-life phase blood and tissue sample collection
•Single and repeat dose MTD study
•In vivo pharmacokinetics and GLP toxicity studies of drugs in rats, mice, rabbits£¬canines and non-human primates